Gene Therapy For Rare Disease Market Size And Share

  • Report Code : TIPRE00003413
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Analyse des parts de marché et des principaux résultats du marché de la thérapie génique pour les maladies rares d'ici 2025-2031

Buy Now

Gene Therapy For Rare Disease Market Report Gene Therapy For Rare Disease Market Scope and Analysis Gene Therapy For Rare Disease Market Size and Share

Gene Therapy For Rare Disease Market Report Analysis

Gene Therapy For Rare Disease Market

  • CAGR (2023 - 2031)
    XX%
  • Market Size 2023
    US$ XX million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • BioMarin
  • Orchard Therapeutics plc.
  • Spark Therapeutics, Inc.
  • PTC Therapeutics
  • bluebird bio, Inc.
  • Kite Pharma
  • uniQure N.V.
  • Juno Therapeutics Inc. (Celgene Corporation)
  • Novartis AG

Regional Overview

  • Amérique du Nord
  • Europe
  • Asie-Pacifique
  • Amérique du Sud et centrale
  • Moyen-Orient et Afrique

Market Segmentation

By Application thérapeutique
  • oncologie
  • troubles neurologiques
  • troubles ophtalmiques
  • troubles hématologiques
  • troubles d'immunodéficience
  • troubles métaboliques
  • autres
By Géographie
  • Amérique du Nord
  • Europe
  • Asie-Pacifique
  • Amérique du Sud et Centrale